We’re the only nation that can’t control our drug prices. The reason we can’t control them is because big Pharma has bought the government, and we let it. ~ Editor
Pharmaceutical companies just raised list prices for over 500 medicines, including Novo Nordisk’s Ozempic, Gilead’s HIV-1 treatment Biktarvy and Genentech’s hemophilia A medication Hemlibra.
Drugmakers typically increase prices in the U.S. every January, according to 46brooklyn Research, a nonprofit group that analyzes drug prices. And although this month’s price hikes are comparable with those in recent years, consumers and insurance companies will likely feel the impact. Continue reading